Replying to @JuddLegum
We were not aware of Senator Hyde-Smith’s remarks when this contribution was made on November 8, and we have requested a refund. We reject the Senator’s statements, which are not aligned with our company’s core values.
Boston Scientific
2,935 posts
Boston Scientific
@bostonsci
Official news from Boston Scientific, a leading innovator of less invasive medical solutions that transform lives. Find us on Facebook, LinkedIn, and Instagram.
- We have received FDA authorization in partnership with @UMNMDC for the Coventor, a low-cost emergency ventilator alternative. Read more on @business: bit.ly/2VbvIhB #Covid19
- Recruiting diverse patient populations in clinical trials is critical in the transition to value based care: bit.ly/2wnk9Eu
- Replying to @bostonsciWe were not aware of Senator Hyde-Smith’s remarks when this contribution was made on November 8, and we have requested a refund. We reject the Senator’s statements, which are not aligned with our company’s core values.
- Replying to @JuddLegum @Walmart and 4 othersWe were not aware of Senator Hyde-Smith’s remarks when this contribution was made on November 8, and we have requested a refund. We reject the Senator’s statements, which are not aligned with our company’s core values.
- We are saddened to share the news that co-founder and former Chairman and CEO Pete Nicholas passed away at age 80. In the words of CEO Mike Mahoney, “all of us are able to be part of this company today because of Pete’s 35+ years of entrepreneurialism and enduring leadership.”
- We’re excited to announce that we’ve exercised our option to acquire @farapulse, whose FARAPULSE Pulsed Field Ablation System is the first commercialized technology of its kind, with CE Mark in Europe and a pivotal IDE underway in the U.S. bit.ly/35RqEDw $BSX
- Chronic pain affects 50 million people in the U.S. alone – hear how a medical device is helping one veteran manage his pain: bit.ly/2YInrBv
- At Boston Scientific, diversity is not just an admirable goal - it is a core value and a business imperative.
- #BigData on its own won’t change lives. Our Chief Digital Health Officer sounds off on finding the “critical bit” of data that can make all the difference: bit.ly/2mq6vyd #CPCIoT
- We've manufactured and donated over 1 million face shields to health care facilities across the U.S. in collaboration with @amazon and @getusppe. bit.ly/2WlHjLt
- We are excited to announce the acquisition of Obsidio, Inc., developer of the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. bit.ly/3AjCBSC
- Our CEO Mike Mahoney earned the number 2 spot on the 2018 @Glassdoor #TopCEOs list based on employee feedback! bit.ly/2I7jUmB
